Hepatic stellate cell enriched Asporin drives liver fibrosis by stabilizing ERH to promote IL-17/MAPK11 signaling

Read full text Summarise with VIRAT
Authors: Jian Sun, Ruoxuan Yang, Mengmeng Liu, Yi Chen, Yu Zhang, Huiying Gao, Zhiwei Ning, Shifen Li, Dina Saifullina, Xiong Tian, Tongzhu Jin, Yingying Guo
+9 more Qianqian Wang, Yixin Zhang, Tengfei Pan, Yu Bian, Erliang Guo, Yanyan Liu, Jing LIU, Tianyu Li, Haihai Liang
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

and high-fat diet induced fibrosis models, prasugrel alleviated fibrosis, inflammation, lipid accumulation, and portal hypertension by suppressing Asporin and ERH expression. Collectively, these findings define the Asporin/ERH/IL-17/MAPK11 axis as a key mediator of HSC activation and fibrogenesis and highlight prasugrel as a promising anti-fibrotic therapy.

Fields of Study & Subjects

Liver physiology and pathology Liver Disease Diagnosis and Treatment Liver Diseases and Immunity

Publication details

Journal / source
Acta Pharmaceutica Sinica B
Volume
16
Issue
7
Pages
4350–4366
Publication date
31 March 2026
Language
EN